Current position:Home >Product >
Pyrrolidinium,1-methyl-1-[(5a,17b)-3-oxoandrostan-17-yl]-, iodide(9CI)
Pyrrolidinium,1-methyl-1-[(5a,17b)-3-oxoandrostan-17-yl]-, iodide(9CI)(10063-02-2)
- Name: Pyrrolidinium,1-methyl-1-[(5a,17b)-3-oxoandrostan-17-yl]-, iodide(9CI)
- Synonyms:1-Methyl-1-(3-oxo-5a-androstan-17b-yl)pyrrolidinium iodide (7CI);Pyrrolidinium, 1-methyl-1-(3-oxo-5a-androstan-17b-yl)-, iodide (8CI); 5a-Androstan-3-one, 17b-(1-pyrrolidinyl)-, methiodide; Androstane, pyrrolidinium deriv.; 17b-Pyrrolidin-1'-yl-5a-androstan-3-one methiodide
- Molecular Formula:C24H40 N O . I
- Molecular Weight:
- CAS Registry Number:10063-02-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 84667-04-9/(1R,6R,10S)-4α,10-Bis(acetyloxy)-5α-[(S)-1,5-dimethyl-4-hexenyl]-2-methylenebicyclo[4.3.1]dec-7-ene-7-carbaldehyde
- 428-65-9/2-Chloro-1,1-difluoro-1-methoxyethane
- 68109-71-7/N-Tridecylglycine
- 133147-06-5/methyl 5-(methoxycarbamoyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylate
- 67801-11-0/5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol
- 78812-05-2/[(6-methylquinolin-4-yl)(phenylammonio)methylidene]ammonium dichloride
- 31597-16-7/1,4-Cyclohexanedimethanamine,N,N'-bis[(1,2-dihydro-5-acenaphthylenyl)methyl]-N,N'-dimethyl-,dihydrochloride, trans- (9CI)
- 275-97-8/2l4-Cyclohepta[1,2,5]thiadiazole(9CI)
- 97581-70-9/1-(2-hydroxy-3-propyl-4-{[4-(2H-tetrazol-5-ylmethyl)phenoxy]methyl}phenyl)ethanone
- 63982-07-0/3-(heptanoyloxy)-N,N,N-trimethylanilinium bromide
- 106784-36-5/1,1'-Decamethylenebis[3-phenylquinuclidiniumbromide] (7CI)
- 114691-27-9/airodent-02
- 18794-33-7/Pyridine, 3-(methylthio)- (6CI,8CI,9CI)
- 5347-50-2/1-(4-bromophenyl)-2-[(6-nitro-1H-benzimidazol-2-yl)sulfanyl]ethanone
- 31556-76-0/Monamycin B2 (8CI,9CI)
- 32398-63-3/1-ethyl-3,5-diphenyl-1lambda~4~-thiopyran 1-oxide
- 6634-40-8/2-(2-Cyanoethyl)isothiourea monohydrochloride
- 24479-62-7/1'H-Cholest-3-eno[3,4-b]indole(8CI,9CI)
- 55740-64-2/2-amino-5-bromo-6-chloro-1H-pyrimidin-4-one
- 10063-02-2/Pyrrolidinium,1-methyl-1-[(5a,17b)-3-oxoandrostan-17-yl]-, iodide(9CI)
- 84968-74-1/{2-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl}acetic acid
- 1463-77-0/copper(II) cyanide
- 7478-12-8/(1Z)-1-(1,3-benzodioxol-5-yl)-2-phenylethanone oxime
- 6953-04-4/N-(1-methylethyl)-7H-purine-6-sulfonamide
- 395639-58-4/Siloxanes and Silicones, di-Me, hydroxy-terminated, propoxylated, polymers with polypropylene glycol ether with glycerol (3:1), polypropylene glycol ether with pentaerythritol (4:1) and TDI
- 6939-54-4/1-[bis(2-hydroxyethyl)amino]-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbonitrile
- 112002-32-1/fhuD protein, E coli
- 55401-54-2/9-Octyltetracosane
- 25448-39-9/tetrachloromolybdenum
- 74141-75-6/N-(2,3-dihydroxypropyl)-2-(2-nitro-1H-imidazol-1-yl)acetamide